Cinctive Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-147,818
Closed -$1.83M 490
2024
Q4
$1.83M Sell
147,818
-154,833
-51% -$1.77M 0.09% 227
2024
Q3
$3.44M Buy
302,651
+150,211
+99% +$1.51M 0.19% 177
2024
Q2
$1.09M Buy
152,440
+59,467
+64% +$455K 0.05% 299
2024
Q1
$623K Buy
92,973
+16,289
+21% +$112K 0.03% 330
2023
Q4
$498K Sell
76,684
-109,976
-59% -$709K 0.03% 307
2023
Q3
$1.76M Buy
186,660
+93,204
+100% +$1.12M 0.09% 232
2023
Q2
$1.31M Sell
93,456
-68,829
-42% -$1.17M 0.04% 283
2023
Q1
$3.04M Buy
162,285
+83,230
+105% +$1.37M 0.1% 267
2022
Q4
$1.09M Sell
79,055
-69,813
-47% -$1.07M 0.05% 303
2022
Q3
$2.85M Buy
148,868
+68,700
+86% +$1.25M 0.12% 242
2022
Q2
$1.22M Sell
80,168
-20,895
-21% -$309K 0.05% 372
2022
Q1
$2.06M Buy
101,063
+44,563
+79% +$907K 0.08% 324
2021
Q4
$1.65M Sell
56,500
-37,530
-40% -$1.07M 0.07% 332
2021
Q3
$2.03M Sell
94,030
-107,440
-53% -$2.59M 0.1% 288
2021
Q2
$5.17M Sell
201,470
-88,663
-31% -$1.89M 0.24% 129
2021
Q1
$5.29M Sell
290,133
-94,867
-25% -$1.58M 0.32% 104
2020
Q4
$4.44M Buy
+385,000
New +$3.52M 0.36% 113

Other funds holding CDMO

Cinctive Capital Management's CDMO Position: Q1 2025 in Review

Cinctive Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 147,818 shares — an estimated $1.83M sold.

Cinctive Capital Management first reported a position in CDMO in Q4 2020 and held it in 17 quarters. The position peaked at $5.29M in Q1 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Cinctive Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Cinctive Capital Management sold 147,818 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.83M.
  • Cinctive Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 17 quarters.
  • Cinctive Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $5.29M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Cinctive Capital Management's 13F filing for Q1 2025, filed 15 May 2025.